Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain
· Delayed Price · Currency is EUR 2.890
+0.060 (2.12%)
Apr 24, 2025, 2:35 PM CET
Laboratorio Reig Jofre Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 338.9 | 317.95 | 274.21 | 239.87 | 233.76 | Upgrade
|
| Revenue Growth (YoY) | 6.59% | 15.95% | 14.32% | 2.61% | 13.57% | Upgrade
|
| Cost of Revenue | 137.68 | 141.06 | 119.12 | 96.9 | 94.93 | Upgrade
|
| Gross Profit | 201.22 | 176.89 | 155.09 | 142.97 | 138.83 | Upgrade
|
| Selling, General & Admin | 87.75 | 89.79 | 81.87 | 73.9 | 75.55 | Upgrade
|
| Other Operating Expenses | 75.38 | 51.96 | 42.79 | 41.75 | 36.74 | Upgrade
|
| Operating Expenses | 186.49 | 164.9 | 145.72 | 133.7 | 129.27 | Upgrade
|
| Operating Income | 14.73 | 11.99 | 9.37 | 9.28 | 9.57 | Upgrade
|
| Interest Expense | -0.67 | -0.75 | -0.69 | -0.68 | -0.68 | Upgrade
|
| Interest & Investment Income | - | 0.06 | 0.1 | 0.05 | 0.03 | Upgrade
|
| Earnings From Equity Investments | -0.12 | 0.98 | 1.59 | 0.09 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.07 | 0.06 | -0.36 | 0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.26 | -0.15 | -0.7 | -2.15 | -2.29 | Upgrade
|
| EBT Excluding Unusual Items | 14.2 | 12.21 | 9.74 | 6.23 | 6.79 | Upgrade
|
| Impairment of Goodwill | - | -1 | -0.4 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.72 | -0.57 | -0.44 | -0.36 | Upgrade
|
| Asset Writedown | -2.38 | - | - | 0 | - | Upgrade
|
| Pretax Income | 11.82 | 10.5 | 8.76 | 5.79 | 6.43 | Upgrade
|
| Income Tax Expense | 1.36 | 1.1 | 0.66 | 0.71 | 0.76 | Upgrade
|
| Earnings From Continuing Operations | 10.47 | 9.4 | 8.11 | 5.08 | 5.67 | Upgrade
|
| Minority Interest in Earnings | - | 0.01 | 0 | 0.01 | 0.01 | Upgrade
|
| Net Income | 10.47 | 9.41 | 8.11 | 5.09 | 5.67 | Upgrade
|
| Net Income to Common | 10.47 | 9.41 | 8.11 | 5.09 | 5.67 | Upgrade
|
| Net Income Growth | 11.27% | 16.04% | 59.21% | -10.23% | 14.77% | Upgrade
|
| Shares Outstanding (Basic) | - | 79 | 79 | 78 | 77 | Upgrade
|
| Shares Outstanding (Diluted) | - | 79 | 79 | 78 | 77 | Upgrade
|
| Shares Change (YoY) | - | -0.10% | 1.32% | 1.13% | 7.99% | Upgrade
|
| EPS (Basic) | - | 0.12 | 0.10 | 0.07 | 0.07 | Upgrade
|
| EPS (Diluted) | - | 0.12 | 0.10 | 0.07 | 0.07 | Upgrade
|
| EPS Growth | - | 19.37% | 52.89% | -6.56% | 0.97% | Upgrade
|
| Free Cash Flow | - | 6.65 | 5.2 | -4.73 | 6.75 | Upgrade
|
| Free Cash Flow Per Share | - | 0.08 | 0.07 | -0.06 | 0.09 | Upgrade
|
| Dividend Per Share | 0.040 | 0.040 | 0.040 | 0.040 | 0.045 | Upgrade
|
| Dividend Growth | - | - | - | -11.11% | - | Upgrade
|
| Gross Margin | 59.38% | 55.63% | 56.56% | 59.60% | 59.39% | Upgrade
|
| Operating Margin | 4.35% | 3.77% | 3.42% | 3.87% | 4.09% | Upgrade
|
| Profit Margin | 3.09% | 2.96% | 2.96% | 2.12% | 2.43% | Upgrade
|
| Free Cash Flow Margin | - | 2.09% | 1.90% | -1.97% | 2.89% | Upgrade
|
| EBITDA | 31.04 | 28.3 | 22.56 | 20.36 | 20.32 | Upgrade
|
| EBITDA Margin | 9.16% | 8.90% | 8.23% | 8.49% | 8.69% | Upgrade
|
| D&A For EBITDA | 16.31 | 16.31 | 13.19 | 11.08 | 10.75 | Upgrade
|
| EBIT | 14.73 | 11.99 | 9.37 | 9.28 | 9.57 | Upgrade
|
| EBIT Margin | 4.35% | 3.77% | 3.42% | 3.87% | 4.09% | Upgrade
|
| Effective Tax Rate | 11.46% | 10.47% | 7.51% | 12.31% | 11.83% | Upgrade
|
| Advertising Expenses | - | 12.96 | 10.99 | 9 | 8.38 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.